BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic disorders. Its products pipeline comprises BRTX-100, a...
216 insider purchases on record · latest filing 2024-04-10.
Insiders have also filed 6 sale transactions at BRTX.